Ad Hoc Percutaneous Coronary Intervention Study in Acute Coronary Syndrome Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

343

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Acute Coronary Syndrome
Interventions
DRUG

Ticagrelor

180 mg loading dose

DRUG

Clopidogrel

600 mg loading dose

Trial Locations (16)

Unknown

Research Site, Birmingham

Research Site, San Francisco

Research Site, Washington D.C.

Research Site, Jacksonville

Research Site, Ypsilanti

Research Site, Minneapolis

Research Site, Tupelo

Research Site, North Kansas City

Research Site, Belleville

Research Site, New York

Research Site, The Bronx

Research Site, Greensboro

Research Site, Cincinnati

Research Site, Oklahoma City

Research Site, Tyler

Research Site, Richmond

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY